This week, we explored the first letter of the BE CLEAR Method acronym: “B” for breathing. “BE” also serves as a handy shorthand for bronchiectasis, a rather lengthy term that takes a while to master.
Another “B” worth mentioning is brensocatib, an Insmed-developed drug currently undergoing trials for non-cystic fibrosis bronchiectasis (NCFBE) with over 1,700 participants. This marks the largest BE drug trial to date. I’ll share an update on its progress in my upcoming winter newsletter.
In the meantime, why not consider ordering Insmed’s FREE book, “SEEN”? Featuring the stories of four women with bronchiectasis, three of whom use oxygen, the book offers valuable insights and practical tips.
You can find the link to order the book on speakupinbronchiectasis.com
Breath deeply knowing that treatments are on the way!!
#Brensocatib #Insmed #ClinicalTrials #Bronchiectasis #COPD #Asthma
Linda Cooper Esposito, MPH is a health educator with bronchiectasis. She developed the BE CLEAR Method to Living with Bronchiectasis and writes with compassion and humor about this chronic lung disease.